Cargando…
Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival
Antibody-mediated rejection (AMR) is an important cause of graft loss after organ transplantation. It is caused by anti-donor-specific antibodies especially anti-HLA antibodies. C4d had been regarded as a diagnosis marker for AMR. Although most early AMR episodes can be successfully controlled or re...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816029/ https://www.ncbi.nlm.nih.gov/pubmed/24222777 http://dx.doi.org/10.1155/2013/859761 |
_version_ | 1782289479702151168 |
---|---|
author | Sun, Qiquan Yang, Yang |
author_facet | Sun, Qiquan Yang, Yang |
author_sort | Sun, Qiquan |
collection | PubMed |
description | Antibody-mediated rejection (AMR) is an important cause of graft loss after organ transplantation. It is caused by anti-donor-specific antibodies especially anti-HLA antibodies. C4d had been regarded as a diagnosis marker for AMR. Although most early AMR episodes can be successfully controlled or reversed, late and chronic AMR remains the leading cause of late graft loss. The strategies which work in early AMR have limited effect on late/chronic episodes. Here, we reviewed the lines of evidence that late/chronic AMR is the leading cause of late graft loss, characteristics of late AMR, and current strategies in managing late/chronic AMR. More effort should be put on the management of late/chronic AMR to make a better long term graft survival. |
format | Online Article Text |
id | pubmed-3816029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38160292013-11-11 Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival Sun, Qiquan Yang, Yang Clin Dev Immunol Review Article Antibody-mediated rejection (AMR) is an important cause of graft loss after organ transplantation. It is caused by anti-donor-specific antibodies especially anti-HLA antibodies. C4d had been regarded as a diagnosis marker for AMR. Although most early AMR episodes can be successfully controlled or reversed, late and chronic AMR remains the leading cause of late graft loss. The strategies which work in early AMR have limited effect on late/chronic episodes. Here, we reviewed the lines of evidence that late/chronic AMR is the leading cause of late graft loss, characteristics of late AMR, and current strategies in managing late/chronic AMR. More effort should be put on the management of late/chronic AMR to make a better long term graft survival. Hindawi Publishing Corporation 2013 2013-10-08 /pmc/articles/PMC3816029/ /pubmed/24222777 http://dx.doi.org/10.1155/2013/859761 Text en Copyright © 2013 Q. Sun and Y. Yang. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Sun, Qiquan Yang, Yang Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival |
title | Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival |
title_full | Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival |
title_fullStr | Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival |
title_full_unstemmed | Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival |
title_short | Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival |
title_sort | late and chronic antibody-mediated rejection: main barrier to long term graft survival |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816029/ https://www.ncbi.nlm.nih.gov/pubmed/24222777 http://dx.doi.org/10.1155/2013/859761 |
work_keys_str_mv | AT sunqiquan lateandchronicantibodymediatedrejectionmainbarriertolongtermgraftsurvival AT yangyang lateandchronicantibodymediatedrejectionmainbarriertolongtermgraftsurvival |